Distinguished in Nearsightedness

Nicolas Leveziel

University Paris Est, 
Creteil, FR 
Distinguished in Nearsightedness
University Paris Est, 
Creteil, FR 
OverviewLocationsClinical Research

Overview

Nicolas Leveziel practices in Creteil, France. Mr. Leveziel is rated as a Distinguished expert by MediFind in the treatment of Nearsightedness. His top areas of expertise are Nearsightedness, Age-Related Macular Degeneration (ARMD), Late-Onset Retinal Degeneration, and Retinopathy Pigmentary Mental Retardation.

His clinical research consists of co-authoring 69 peer reviewed articles and participating in 4 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 22 articles in the study of Nearsightedness.

Gender
Male

Locations

University Paris Est, Creteil, France

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

4 Clinical Trials

Pilot and Phase 2 Study of the Efficacy of a Treatment Protocol With Dexamethasone Implant Loading Dose in Patients With Diabetic Macular Edema
Pilot and Phase 2 Study of the Efficacy of a Treatment Protocol With Dexamethasone Implant Loading Dose in Patients With Diabetic Macular Edema
Enrollment Status: Active_not_recruiting
Publish Date: November 19, 2025
Intervention Type: Drug
Study Drug: Dexamethasone
Study Phase: Phase 2
Phase 2 Study of Safety and Efficacy of Aflibercept in Proliferative Diabetic Retinopathy.
Phase 2 Study of Safety and Efficacy of Aflibercept in Proliferative Diabetic Retinopathy.
Enrollment Status: Completed
Publish Date: March 10, 2020
Intervention Type: Procedure, Drug
Study Phase: Phase 2
Effect of Bevacizumab Subconjunctival Injections on Corneal Newvessels
Effect of Bevacizumab Subconjunctival Injections on Corneal Newvessels
Enrollment Status: Completed
Publish Date: October 24, 2019
Intervention Type: Drug
Study Phase: Phase 3
Impact on Daily Life of Patients Using the Subretinal Implant RETINA IMPLANT Alpha AMS
Impact on Daily Life of Patients Using the Subretinal Implant RETINA IMPLANT Alpha AMS
Enrollment Status: Terminated
Publish Date: April 19, 2019
Intervention Type: Device
Study Phase: Not Applicable
View 3 Less Clinical Trials

69 Total Publications

Factors Affecting the Lifetime Cost of Myopia and the Impact of Active Myopia Treatments in Europe.
Factors Affecting the Lifetime Cost of Myopia and the Impact of Active Myopia Treatments in Europe.
Journal: American journal of ophthalmology
Published: February 28, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Leveziel's expertise for a condition
ConditionClose
    View All 16 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile